blue cross blue shield reverse course on glp 1 Why is rolling back coverage of GLP-1 weight loss drugs in Massachusetts Blue Cross Blue Shield of

Then the dominoes: the LIFT-AD trial failed in September 2024, the Department of Justice settlement landed in January 2025, and the formal retractions of two foundational papers followed in April 2025

A potential mechanism for cytokine-mediated insulin resistance

More about the management of these shortages For the past 2 years, EMA and the EU regulatory network have been closely monitoring these shortages through the Medicine Shortages SPOC WP and the MSSG

Now, every book, including Super Agers , I try to forecast the future, and Ive always been wrong, not by what was going to happen, but when, because it takes much longer for medicine to reset and change

This is perfect for patients who cannot absorb vitamins well through digestion

Keeping your body hydrated is critical on GLP-1 medications to keep you feeling your best and avoid side effects